Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
11/11/2003 | US6645745 Cytochrome P-450 (CYP) heme proteins mediating a varitey of metabolic processes; use to identify/obtain drug candidates or inhibitors for therapy of disorders related to malfunction of human CYP encoding genes such as cancer |
11/11/2003 | US6645739 Genetic engineering; for production of enzymes, growth factors, cytokines, immunogenic proteins, and immunoglobulin proteins |
11/11/2003 | US6645736 Calcium independent cytosolic phospholipase A2/B enzymes |
11/11/2003 | US6645728 Genetically engineered enzymatic protein; for use in modulating apotosis, swelling and immune response |
11/11/2003 | US6645501 Anti-pathogen system and methods of use thereof |
11/11/2003 | CA2293695C Protease enzymes for tough cleaning and/or spot and film reduction and compositions incorporating same |
11/11/2003 | CA2132344C Super porous polysaccharide gels |
11/06/2003 | WO2003091835A2 Computationally targeted evolutionary design |
11/06/2003 | WO2003091459A1 Cells for detection of influenza and parainfluenza viruses |
11/06/2003 | WO2003091441A1 Sfr2 protein encoding gene |
11/06/2003 | WO2003091436A1 Novel 35 kd protein |
11/06/2003 | WO2003091431A1 Methylotroph producing mammalian type sugar chain |
11/06/2003 | WO2003091423A1 Adh from rhodococcus erythropolis |
11/06/2003 | WO2003091422A1 Mutated alkaline cellulase |
11/06/2003 | WO2003091420A2 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides |
11/06/2003 | WO2003091419A2 Kinases and phosphatases |
11/06/2003 | WO2003091418A2 Novel essential fungal polynucleotides, polypeptides, and methods of use |
11/06/2003 | WO2003091411A2 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor |
11/06/2003 | WO2003091403A2 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases |
11/06/2003 | WO2003091402A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS |
11/06/2003 | WO2003091397A2 Methods and compositions for regulating cellular signaling |
11/06/2003 | WO2003091396A2 Polypeptides and biosynthetic pathways |
11/06/2003 | WO2003091266A2 Protein stabilisation using chaperone proteins |
11/06/2003 | WO2003091264A2 Non nucleoside reverse transcriptase inhibitors |
11/06/2003 | WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds |
11/06/2003 | WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
11/06/2003 | WO2003090688A2 Enhancement of human epidermal melanogenesis |
11/06/2003 | WO2003068153A3 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE |
11/06/2003 | WO2003059945A3 Soluble recombinant protein production |
11/06/2003 | WO2003054153A3 Apyrase polypeptides and nucleic acids encoding same |
11/06/2003 | WO2003054139A3 Compositions and methods utilizing dna polymerases |
11/06/2003 | WO2003052092A3 Method for the inactivation of amylase in the presence of protease |
11/06/2003 | WO2003048378A3 Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture |
11/06/2003 | WO2003031939A3 Protein modification and maintenance molecules |
11/06/2003 | WO2003023355A3 Serine/threonine hydrolase proteins and screening assays |
11/06/2003 | WO2003020922A3 Enzymes involved in cell wall biosynthesis in filamentous fungi |
11/06/2003 | WO2003020885B1 Identification of sortase gene |
11/06/2003 | WO2003016515A3 Regulation of human glycerol-3-phosphate acyltransferase-like protein |
11/06/2003 | WO2003012071A3 Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use |
11/06/2003 | WO2003012031A3 Antisense modulation of stearoyl-coa desaturase expression |
11/06/2003 | WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
11/06/2003 | WO2003009855A3 Organo-phosphorous compounds for activating gamma/delta t cells |
11/06/2003 | WO2003008588A3 Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase |
11/06/2003 | WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c |
11/06/2003 | WO2003006674A3 CRYSTALS AND STRUCTURES OF ArnB AMINOTRANSFERASES |
11/06/2003 | WO2003006617A3 Crystals and structures of perosamine synthase homologs |
11/06/2003 | WO2003006602A3 Subtilase variants |
11/06/2003 | WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay |
11/06/2003 | WO2003005880A3 Replikin peptides and uses thereof |
11/06/2003 | WO2003001983A3 Methods for diagnosing and treating a disease mediated by decreased mmp-2 function |
11/06/2003 | WO2002090523A3 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
11/06/2003 | WO2002086126A3 Enzymatic method for the enantioselective reduction of keto compounds |
11/06/2003 | WO2002083854A9 Antibodies to vla-1 |
11/06/2003 | WO2002081741A3 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection |
11/06/2003 | WO2002081714A3 Overexpression of phosphoenolpyruvate carboxylase |
11/06/2003 | WO2002079258A3 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations |
11/06/2003 | WO2002068666A8 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
11/06/2003 | WO2002068575A8 Liquid detergent composition exhibiting enhanced α-amylase enzyme stability |
11/06/2003 | WO2002066662A8 Process for the preparation of perillyl alcohol |
11/06/2003 | WO2002063025A3 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
11/06/2003 | WO2002061066A8 Method for producing an enzyme from a novel source |
11/06/2003 | WO2002057792A3 Affinity selection-based screening of hydrophobic proteins |
11/06/2003 | WO2002053742A3 Proteins and nucleic acids encoding same |
11/06/2003 | WO2002046437A3 Methods and compositions for highly efficient production of heterologous proteins in yeast |
11/06/2003 | WO2002046379A3 Glucuronyl c5-epimerase, dna encoding the same and uses thereof |
11/06/2003 | WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
11/06/2003 | WO2002018369A8 Peptidomimetic protease inhibitors |
11/06/2003 | WO2002009639A3 Methods and pharmaceutical compositions for healing wounds |
11/06/2003 | WO2002004648A8 Methods for regulating beta-oxidation in plants |
11/06/2003 | US20030208794 Gene targeting using replicating DNA molecules |
11/06/2003 | US20030208791 Enzymes involved in triterpene synthesis |
11/06/2003 | US20030208788 Comprises substitutions in a number of positions corresponding to a position in the phytase; variants are of improved properties like higher thermostability; used in animal feeds |
11/06/2003 | US20030208057 Mammalian genes modulated during fasting and feeding |
11/06/2003 | US20030208056 Two novel camp-specific phosphodiesterase (pde4b)isoforms and related technology |
11/06/2003 | US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/06/2003 | US20030208054 Fc Receptors and polypeptides |
11/06/2003 | US20030208044 Galectin 11 |
11/06/2003 | US20030207947 Production of lutein in microorganisms |
11/06/2003 | US20030207840 Solid tumors and other conditions related to angiogenesis, including wounds, bone fractures, follicular development, ischemia, retinopathy, psoriasis, and rheumatoid arthritis are treated or detected with reagents which either detect, |
11/06/2003 | US20030207830 Mutant NDP kinases for antiviral nucleotide analog activation and therapeutic uses thereof |
11/06/2003 | US20030207808 Novel nucleic acid and amino acid sequences |
11/06/2003 | US20030207806 Insecticidal protein toxins from Photorhabdus |
11/06/2003 | US20030207800 Proteins, polynucleotides encoding them and methods of using the same |
11/06/2003 | US20030207796 Specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an alpha 2-6 linkage are able to inhibit the conversion of human Factor X |
11/06/2003 | US20030207442 Method for detecting the presence of an analyte in a sample |
11/06/2003 | US20030207437 Preparation of acariogenic sugar substitutes |
11/06/2003 | US20030207436 From an N-acyl-D-amino acid, wherein a minimum reaction rate is specified when forming D-tryptophan from N-acetyl-D-tryptophan in an aqueous medium |
11/06/2003 | US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins |
11/06/2003 | US20030207434 Phosphodiesterases |
11/06/2003 | US20030207433 Nucleotide-sugar-synthesizing enzymes from nonparasitic protists |
11/06/2003 | US20030207432 For refractory injuries, having human leukocyte elastase inhibitory activity |
11/06/2003 | US20030207430 For diagnosis, therapy, and prevention of disorders related to aberrant expression |
11/06/2003 | US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/06/2003 | US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/06/2003 | US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/06/2003 | US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/06/2003 | US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
11/06/2003 | US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/06/2003 | US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
11/06/2003 | US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same |